未登录

C

Carine Beysen

University of California System

H指数:25

被引数:4,483

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2021-12-1544

OA

Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers

NEUROPSYCHOPHARMACOLOGY

IF7.1

2021-12-099

OAAI

Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials

DIABETES OBESITY & METABOLISM

IF5.7

2020-12-2138

OAAI

Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2020-11-2510

PREAI

Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Subjects with T1DM and T2DM

IF7.5

2020-06-011

PRE

Evaluation of the Analytical Performance of YSI 2900D Compared with YSI 2300 STAT Plus for Glucose Concentration Measurements

IF7.5

2020-06-010

PRE

Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)

IF7.5

2020-06-011

PRE

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2019-12-1439

OAAI

Insulin sensitivity and glucose metabolism of olanzapine and a combination of olanzapine and samidorphan: phase 1 study in healthy volunteers

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-12-010

PREAI

NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects

IF7.5

2019-06-0122

PRE

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2019-05-1544

PREAI

Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion

SCIENTIFIC REPORTS

IF3.9

2019-03-0733

OAAI

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

乙酰辅酶a羧化酶抑制逆转NAFLD和肝脏胰岛素抵抗，但促进啮齿动物的高甘油三酯血症

IF15.8

2018-11-29196

OAAI

Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IF3.3

2018-11-0121

OAAI

Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model

在翻译NASH小鼠模型中揭示NASH相关纤维化发作的预测性分子特征

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY

IF7.4

2018-01-0151

OAAI

Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY

IF7.4

2017-09-0116

OAAI

Acetyl-Coenzyme A Carboxylase Inhibition Reduces De Novo Lipogenesis in Overweight Male Subjects: A Randomized, Double-Blind, Crossover Study

IF15.8

2017-07-05102

OAAI

Systems biology approach to identify processes and early markers for fibrosis in metabolically-induced non-alcoholic steatosis hepatitis in mice

JOURNAL OF HEPATOLOGY

IF33

2017-01-010

PREAI

Identifying Nonalcoholic Fatty Liver Disease Patients With Active Fibrosis by Measuring Extracellular Matrix Remodeling Rates in Tissue and Blood

IF15.8

2017-01-0183

OAAI

Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury

JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IF4.9

2016-03-0120

OAAI